| Income Statement |
| Operating Expenses | 1.29M |
|
| Research and Development Expense | 3.00K |
| Selling, General and Administrative Expense | 1.29M |
| Operating Income | -1.29M |
| Net Income | -1.17M |
| Net Income Common Stock | -1.17M |
| Net Income Common Stock (USD) | -1.17M |
| Consolidated Income | -1.17M |
| Earnings per Basic Share | -0.32 |
| Earnings per Basic Share (USD) | -0.32 |
| Earnings per Diluted Share | -0.32 |
| Earning Before Interest & Taxes (EBIT) | -1.17M |
| Earning Before Interest & Taxes (USD) | -1.17M |
| Weighted Average Shares | 3.65M |
| Weighted Average Shares Diluted | 3.65M |
| Balance Sheet |
| Cash and Equivalents | 4.02M |
| Cash and Equivalents (USD) | 4.02M |
| Investments | 7.00K |
| Investments Non-Current | 7.00K |
| Current Assets | 4.49M |
| Total Assets | 4.50M |
| Current Liabilities | 905.00K |
| Total Liabilities | 905.00K |
| Accumulated Retained Earnings (Deficit) | -303.49M |
| Shareholders Equity | 3.59M |
| Shareholders Equity (USD) | 3.59M |
| Assets Non-Current | 7.00K |
| Trade and Non-Trade Payables | 651.00K |
| Cash Flow |
| Net Cash Flow from Financing | 1000.00K |
| Net Cash Flow / Change in Cash & Cash Equivalents | -67.00K |
| Net Cash Flow from Operations | -1.07M |
| Share Based Compensation | 3.00K |